India has made major progress against HIV, but the epidemic is not over. The country has reduced new infections and AIDS-related deaths substantially since 2010, expanded free antiretroviral therapy (ART), increased HIV testing, and built a national network for prevention, treatment, surveillance, and community support. At the same time, more than 2.5 million people are living with HIV in India, and important gaps remain in diagnosis, treatment access, stigma reduction, prevention, and state-level equity.
The most useful way to understand HIV/AIDS in India today is not through statistics from the early 2010s. India now has newer national estimates. The India HIV Estimation 2025 Technical Report from the National AIDS Control Organisation (NACO) estimates that in 2024 India had about 25.61 lakh people living with HIV, equivalent to roughly 2.56 million people. Adult HIV prevalence among people ages 15–49 was estimated at 0.20%.
India therefore has a relatively low national adult prevalence compared with some countries, but its very large population means the absolute number of people living with HIV is substantial. HIV is also unevenly distributed across states, populations, and communities, so a national average can hide areas with much higher local prevalence.
HIV and AIDS Are Not the Same Thing
HIV stands for human immunodeficiency virus. It attacks cells that help the immune system fight infection.
AIDS is the most advanced stage of HIV infection. A person can live with HIV for many years without developing AIDS when effective treatment is available and taken consistently.
The World Health Organization explains that there is currently no cure for HIV, but modern antiretroviral treatment can make HIV a manageable chronic condition and allow people to live long, healthy lives.
How Many People Are Living With HIV in India?
According to India HIV Estimation 2025, the estimated HIV burden for 2024 included:
- 25.61 lakh people living with HIV;
- 0.20% adult HIV prevalence among ages 15–49;
- about 64,470 new HIV infections during the year;
- about 32,200 AIDS-related deaths.
The estimates include uncertainty ranges because HIV burden cannot be measured by simply counting every person with the virus. National surveillance, testing, program data, and statistical models are combined to estimate the epidemic.
India Has Reduced New HIV Infections
One of the most important trends is the long-term decline in new infections.
NACO estimates that annual new HIV infections fell by about 48.7% between 2010 and 2024. This represents substantial progress, but tens of thousands of people are still acquiring HIV each year.
Prevention therefore remains necessary even as treatment expands.
AIDS-Related Deaths Have Fallen Sharply
India has also experienced a major decline in AIDS-related mortality.
Government reporting around the 2025 World AIDS Day observance indicated an approximately 81% decline in AIDS-related deaths from 2010 to 2024. The estimated number of AIDS-related deaths in 2024 was around 32,200.
The decline reflects several factors, especially wider access to ART, earlier diagnosis, better clinical management, and viral-load monitoring.
India’s National AIDS Control Programme
India’s organized national response began decades ago and has evolved through multiple phases of the National AIDS Control Programme (NACP).
The current major phase, NACP-V, covers 2021–2026 and focuses on accelerating progress toward ending AIDS as a public-health threat while improving the quality and reach of prevention and treatment services.
India’s HIV response is led by NACO under the Ministry of Health and Family Welfare, working with State AIDS Control Societies, health facilities, community organizations, civil-society partners, laboratories, and other agencies.
HIV Testing Has Expanded
Testing is essential because people cannot benefit from HIV treatment until they know their status.
Government data released in 2025 reported that HIV testing increased from about 4.13 crore tests in 2020–21 to 6.62 crore in 2024–25.
Testing can occur through different services, including:
- integrated counseling and testing centers;
- health facilities;
- antenatal services;
- targeted community programs;
- blood screening;
- other approved testing pathways.
Free Antiretroviral Treatment
India provides free ART through its public HIV program.
By 2024–25, government reporting indicated that approximately 18.6 lakh people were receiving antiretroviral treatment through the national response.
ART works by suppressing HIV replication. Effective treatment helps the immune system recover and dramatically reduces the risk of illness and death.
Undetectable = Untransmittable
Modern HIV treatment is also a powerful prevention tool.
The CDC’s Undetectable = Untransmittable guidance explains that a person living with HIV who takes treatment and maintains an undetectable viral load has zero risk of sexually transmitting HIV to partners.
This is often summarized as U=U.
U=U is important for both public health and stigma reduction. HIV treatment should not be described merely as something that delays disease. When successful, it allows people to live healthy lives and prevents sexual transmission.
Viral-Load Testing
A viral-load test measures the amount of HIV in the blood.
It helps clinicians determine whether ART is effectively suppressing the virus. India has expanded viral-load testing substantially, with government figures reporting an increase from about 8.9 lakh tests in 2020–21 to nearly 16 lakh in 2024–25.
Regular monitoring matters because treatment failure, adherence difficulties, drug interactions, or resistance may require clinical attention.
How HIV Is Transmitted
HIV can be transmitted through specific body fluids when sufficient virus reaches another person’s bloodstream or susceptible tissue.
Important transmission routes include:
- anal or vaginal sex when effective prevention is not being used;
- sharing contaminated needles, syringes, or injecting equipment;
- transmission during pregnancy, childbirth, or breastfeeding without effective prevention and treatment;
- unsafe blood transfusion or contaminated medical equipment where screening and infection-control systems fail.
How HIV Is Not Transmitted
HIV is not spread through ordinary social contact.
You do not acquire HIV from:
- hugging;
- shaking hands;
- sharing a toilet;
- sharing ordinary dishes or utensils;
- working or studying beside a person with HIV;
- mosquito bites.
Correcting these misconceptions is essential because fear of casual transmission contributes directly to stigma and discrimination.
Sexual Transmission and Prevention
Sexual transmission remains an important part of the epidemic.
Prevention options include:
- HIV testing;
- correct and consistent condom use;
- early diagnosis and ART;
- testing and treatment for other sexually transmitted infections;
- pre-exposure prophylaxis (PrEP) when clinically appropriate;
- post-exposure prophylaxis (PEP) after a possible significant exposure.
People should receive prevention advice based on their individual circumstances rather than stereotypes about identity or occupation.
PrEP and PEP
PrEP is antiretroviral medication taken by an HIV-negative person to reduce the chance of acquiring HIV.
PEP is a short course of antiretroviral medication started after a possible exposure. It must be started promptly, so someone who believes they have had a significant recent HIV exposure should contact an appropriate healthcare service as soon as possible.
Availability, recommended regimens, and eligibility can vary, so medical guidance is important.
HIV and Injecting Drug Use
Sharing injecting equipment can transmit HIV and other blood-borne infections.
Risk-reduction strategies can include:
- sterile needles and syringes;
- opioid substitution therapy where appropriate;
- HIV and hepatitis testing;
- access to addiction treatment;
- community outreach.
Stigmatizing people who use drugs makes prevention harder because it can push people away from testing and healthcare.
MyArticles’ guide to Alcoholics Anonymous and recovery support discusses how peer support differs from professional medical treatment. HIV prevention for people who inject drugs likewise works best when health services are practical, evidence-based, and nonjudgmental.
Preventing Transmission During Pregnancy and Breastfeeding
HIV can pass from a mother to a child during pregnancy, birth, or breastfeeding, but effective interventions can greatly reduce this risk.
Key components include:
- routine HIV testing during pregnancy;
- early ART for pregnant people living with HIV;
- viral-load monitoring;
- appropriate care for the infant;
- follow-up testing and clinical guidance.
India has made substantial progress reducing vertical transmission since 2010, but elimination has not yet been achieved everywhere.
Blood Safety
Blood safety was one of the earliest priorities of India’s HIV program.
Modern blood services use donor screening and HIV testing to reduce transfusion risk. The goal is to ensure that donated blood and blood products are safe before use.
People should not avoid medically necessary transfusions because of outdated fears about HIV when care is being provided through properly regulated blood services.
Why HIV Prevalence Differs Across States
India’s national prevalence of 0.20% does not mean every state or district has the same epidemic.
Differences can reflect:
- local sexual networks;
- injecting-drug-use patterns;
- migration;
- access to prevention and testing;
- historical epidemic patterns;
- health-service coverage;
- social and economic conditions.
Some northeastern states have historically had substantially higher adult HIV prevalence than the national average, particularly in areas where injecting-drug transmission has been important.
Populations With Higher HIV Burden
Public-health programs often use the term key populations for groups that may experience higher HIV risk because of exposure patterns, social conditions, legal barriers, or limited access to services.
Depending on the setting, these can include:
- men who have sex with men;
- transgender people;
- sex workers;
- people who inject drugs;
- partners and clients within higher-risk sexual networks.
Effective prevention should focus on access to healthcare, testing, treatment, condoms, harm reduction, and rights—not moral judgment.
Stigma Is Still a Public-Health Problem
Stigma can cause people to delay testing, hide their status, avoid healthcare, lose social support, or face discrimination.
Common harmful myths include:
- assuming HIV reveals someone’s morality;
- believing all people with HIV are visibly ill;
- thinking casual contact spreads HIV;
- assuming treatment does not work;
- treating a diagnosis as a reason for social exclusion.
India’s HIV response increasingly emphasizes rights-based and stigma-free services.
HIV and the Right to Healthcare
Ethical HIV care involves more than providing medication. It also requires confidentiality, informed consent, respectful treatment, non-discrimination, and fair access to services.
MyArticles’ discussion of moral principles in healthcare explains why autonomy, beneficence, nonmaleficence, justice, and confidentiality are particularly important when health information can expose someone to stigma.
India’s HIV Program Is Increasingly Domestically Financed
The old version of this article described India’s HIV response mainly through outside donors and early international programs. That picture is now incomplete.
International organizations and partnerships remain important for technical cooperation, research, commodities, and global strategy, but India’s national HIV program has become increasingly institutionalized and domestically supported.
This matters because long-term HIV treatment must continue for decades. Sustainable programs cannot depend only on temporary projects.
The 95-95-95 Goal
The international HIV response uses a cascade known as 95-95-95:
- 95% of people living with HIV know their status;
- 95% of people who know their status receive ART;
- 95% of people on treatment achieve viral suppression.
India has made strong progress but still has gaps, particularly in ensuring that everyone living with HIV is diagnosed and linked to sustained treatment.
Why Diagnosis Remains a Major Challenge
Someone can live with HIV for years without obvious symptoms.
That means symptom-based testing alone will miss infections.
People may also avoid testing because of:
- fear of stigma;
- distance from services;
- concerns about confidentiality;
- low perceived risk;
- lack of awareness;
- fear of discrimination.
Accessible and confidential testing is therefore essential.
HIV Is Now a Long-Term Health Condition for Many People
As treatment improves, HIV care increasingly includes issues associated with long-term health and ageing.
People living with HIV may need ordinary preventive care for:
- heart disease;
- diabetes;
- kidney health;
- bone health;
- mental health;
- cancer screening;
- other infections.
Good HIV care should therefore be integrated with broader primary and specialist healthcare rather than isolated from the rest of medicine.
What India Still Needs to Improve
Major priorities include:
- finding people who remain undiagnosed;
- linking people rapidly to ART;
- retaining people in long-term treatment;
- maintaining viral suppression;
- expanding effective prevention;
- reducing state and district inequalities;
- eliminating vertical transmission;
- reducing stigma and discrimination;
- strengthening services for key populations;
- using surveillance data to target resources.
When to Get Tested
HIV testing may be appropriate after a potential exposure, as part of routine sexual-health care, during pregnancy, or when recommended because of ongoing risk.
Testing windows vary by test type. A negative test taken too soon after exposure may need to be repeated.
Anyone with a very recent significant exposure should seek professional advice promptly because PEP is time-sensitive.
Conclusion
India’s HIV epidemic has changed substantially from the picture presented in older articles. Based on the latest national estimation released in 2025, about 2.56 million people were living with HIV in India in 2024, adult prevalence was approximately 0.20%, annual new infections had declined by nearly half since 2010, and AIDS-related deaths had fallen by more than 80%.
Those gains reflect decades of surveillance, testing, targeted prevention, free ART, blood-safety programs, viral-load monitoring, community engagement, and public-health investment.
But progress should not be confused with completion. India still needs to close diagnosis and treatment gaps, eliminate preventable transmission, improve access for marginalized populations, and reduce stigma.
The central modern message is very different from the fear that surrounded HIV in earlier decades: HIV is preventable, testable, and treatable. People who receive effective ART can live long lives, and those who maintain an undetectable viral load do not sexually transmit HIV.